Clinical Trials Browser

Phase 2 × Terminated × Neurofibromatoses × Clear all

NCT00911248 2019-04-12

PTC299 for Treatment of Neurofibromatosis Type 2

Phase 2 Terminated

Neurofibromatosis 2, Neurofibromatoses

NCT01402817 2018-03-14

Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas

Phase 2 Terminated

19 enrolled 8 charts

Neurofibromatoses, Neurofibroma, Plexiform